Trial Profile
A Prospective Intervention Phase I Study in Three Age De-escalating Group to Assess the Safety and Immunogenicity of Rotavirus (Bio Farma) Vaccine in Adults, Children & Neonates
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Rotavirus vaccine (Primary)
- Indications Rotavirus infections
- Focus Adverse reactions
- Sponsors PT Bio Farma
- 06 Jul 2021 Results assessing the safety with the vaccine virus fecal shedding and immunogenicity of RV3 rotavirus vaccine in adults, children, and neonates, published in the Vaccine.
- 01 Apr 2019 Status changed from recruiting to completed.
- 12 Apr 2018 Status changed from not yet recruiting to recruiting.